article thumbnail

STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials

STAT

The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing. ( See page 42.)

article thumbnail

STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys

STAT

 The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

He warned, “Implementation of a CCS will require more than writing documents.”. Prior to November 2013 he worked for Merck Research Laboratories in Summit, New Jersey as the Senior Principal Scientist in early phase drug development. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.

Vaccines 126
article thumbnail

A Final LDT Rule in April!? Will FDA be prepared?

The FDA Law Blog

OHT-7’s well documented meltdown during the COVID-19 public health emergency should serve as an object lesson. Even if MDUFA VI were to allow the hiring of a significant number of new personnel, implementation of the Proposed Rule would begin before those employees arrive. 4] PRIA at 28. [5] 68006, 68012 (Oct.

FDA 69